"MRI in the detection of malignant infiltration of bone marrow" - A commentary

American Journal of Roentgenology

Volumn 188, Issue 6, 2007, Pages 1443-1445

  Steinbach, Lynne S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone; MRI; Oncology

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

BONE MARROW BIOPSY; BONE MARROW CANCER; BONE MARROW METASTASIS; BONE SCINTISCANNING; BONE TUMOR; CANCER INFILTRATION; CANCER STAGING; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HUMAN; LEUKEMIA; MEDICAL LITERATURE; MULTIPLE MYELOMA; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

BONE MARROW DISEASES; BONE NEOPLASMS; BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE MYELOMA;

EID: 34249912655     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.06.1531     Document Type: Note

References (29)

1. Daffner RH, Lupetin AR, Dash N, Deeb ZL, Sefczek RJ, Schapiro RL. MRI in the detection of malignant infiltration of bone marrow. AJR 1986; 146:353-358
2. Wismer GL, Rosen BR, Buxton R, Stark DD, Brady TJ. Chemical shift imaging of bone marrow: preliminary experience. AJR 1985; 145:1031-1037
3. Ramsey RG, Zacharias CE. MR imaging of the spine after radiation therapy: easily recognizable effects. AJR 1985; 144:1131-1135
4. McKinstry CS, Steiner RE, Young AT, Jones L, Swirsky D, Aber V. Bone marrow in leukemia and aplastic anemia: MR imaging before, during, and after treatment. Radiology 1987; 162:701-707
5. Kaplan PA, Asleson RJ, Klassen LW, Duggan MJ. Bone marrow patterns in aplastic anemia: observations with 1.5-T MR imaging. Radiology 1987; 164:441-444
6. Ruzal-Shapiro C, Berdon WE, Cohen MD, Abramson SJ. MR imaging of diffuse bone marrow replacement in pediatric patients with cancer. Radiology 1991; 181:587-589
7. Moulopoulos LA, Dimopoulos MA, Alexanian R, Leeds NE, Libshitz HI. Multiple myeloma: MR patterns of response to treatment. Radiology 1994; 193:441-446
8. Lecouvet FE, Vande Berg BC, Michaux L, et al. Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging. Radiology 1998; 209:653-660
9. Vande Berg BC, Michaux L, Lecouvet FE, et al. Nonmyelomatous monoclonal gammopathy: correlation of bone marrow MR images with laboratory findings and spontaneous clinical outcome. Radiology 1997; 202:247-251
10. Yankelevitz DF, Henschke CI, Knapp PH, Nisce L, Yi Y, Cahill P. Effect of radiation therapy on thoracic and lumbar bone marrow: evaluation with MR imaging. AJR 1991; 157:87-92
11. Deutsch AL, Mink JH, Rosenfelt FP, Waxman AD. Incidental detection of hematopoietic hyperplasia on routine knee MR imaging. AJR 1989; 152:333-336
12. Sugimura K, Yamasaki K, Kitagaki H, Tanaka Y, Kono M. Bone marrow diseases of the spine: differentiation with T1 and T2 relaxation times in MR imaging. Radiology 1987; 165:541-544
13. Rosen BR, Fleming DM, Kushner DC, et al. Hematologic bone marrow disorders: quantitative chemical shift MR imaging. Radiology 1988; 169:799-804
14. Vande Berg BC, Michaux L, Scheiff IM, et al. Sequential quantitative MR analysis of bone marrow: differences during treatment of lymphoid versus myeloid leukemia. Radiology 1996; 201:519-523
15. Lecouvet FE, Vande Berg BC, Michaux L, et al. Early chronic lymphocytic leukemia: prognostic value of quantitative bone marrow MR imaging findings and correlation with hematologic variables. Radiology 1997; 204:813-818
16. Zajick DC Jr, Morrison WB, Schweitzer ME, Parellada JA, Carrino JA. Benign and malignant processes: normal values and differentiation with chemical shift MR imaging in vertebral marrow. Radiology 2005; 237:590-596
17. Harned EM, Mitchell DG, Burk DL Jr, Vinitski S, Rifkin MD. Bone marrow findings on magnetic resonance images of the knee: accentuation by fat suppression. Magn Reson Imaging 1990; 8:27-31
18. Mirowitz SA, Apicella P, Reinus WR, Hammerman AM. MR imaging of bone marrow lesions: relative conspicuousness on T1-weighted, fat-suppressed T2-weighted, and STIR images. AJR 1994; 162:215-221
19. Steinborn MM, Heuck AF, Tiling R, Bruegel M, Gauger L, Reiser MF. Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system. J Comput Assist Tomogr 1999; 23:123-129
20. Rahmouni A, Montazel JL, Divine M, et al. Bone marrow with diffuse tumor infiltration in patients with lymphoproliferative diseases: dynamic gadolinium-enhanced MR imaging. Radiology 2003; 229:710-717
21. Baur A, Stabler A, Bruning R, et al. Diffusion-weighted MR imaging of bone marrow: differentiation of benign versus pathologic compression fractures. Radiology 1998; 207:349-356
22. Baur A, Dietrich O, Reiser M. Diffusion-weighted imaging of bone marrow: current status. Eur Radiol 2003; 13:1699-1708
23. Yuh WT, Zachar CK, Barloon TJ, Sato Y, Sickels WJ, Hawes DR. Vertebral compression fractures: distinction between benign and malignant causes with MR imaging. Radiology 1989; 172:215-218
24. Rahmouni A, Divine M, Mathieu D, et al. MR appearance of multiple myeloma of the spine before and after treatment. AJR 1993; 160:1053-1057
25. Lecouvet FE, Dechambre S, Malghem J, Ferrant A, Vande Berg BC, Maldague B. Bone marrow transplantation in patients with multiple myeloma: prognostic significance of MR imaging. AJR 2001; 176:91-96
26. Lecouvet FE, Vande Berg BC, Michaux L, et al. Chronic lymphocytic leukemia: changes in bone marrow composition and distribution assessed with quantitative MRI. J Magn Reson Imaging 1998; 8:733-739
27. Hartman RP, Sundaram M, Okuno SH, Sim FH. Effect of granulocyte- stimulating factors on marrow of adult patients with musculoskeletal malignancies: incidence and MRI findings. AJR 2004; 183:645-653
28. Bredella MA, Steinbach L, Caputo G, Segall G, Hawkins R. Value of FDG PET in the assessment of patients with multiple myeloma. AJR 2005; 184:1199-1204
29. Seneterre E, Weissleder R, Jaramillo D, et al. Bone marrow: ultrasmall superparamagnetic iron oxide for MR imaging. Radiology 1991; 179:529-533